The global keytruda market is anticipated to grow at a significant CAGR during the forecast period (2022-2028).Keytruda is an immunotherapy drug that works with the immune system to treat specific malignancies. It may be used in adults and children of 12 years of age and above with stage IIB, stage IIC, or stage III melanoma […]
